Drs. Emily Curran and Justin Kline, University of Chicago Medical Center (IMAGE)

University of Chicago Medical Center

Drs. Emily Curran and Justin Kline, University of Chicago Medical Center

Caption

Drs. Emily Curran and Justin Kline led a team of researchers who demonstrated that that STING is a promising immunotherapeutic target in acute myeloid leukemia.

Credit

The University of Chicago Medicine

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.